SCHEMBL6073564

SCHEMBL6073564

COc1ccc2c(c1)C(C)CC(=O)N2C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.55
ACHE P22303 1/20 0.44
MAPT P10636 3/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
TSHR P16473 2/20 0.42
OPRM1 P35372 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
HTT P42858 1/20 0.40
BRD4 O60885 1/20 0.40
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39
TUBB4B P68371 1/20 0.39
TUBB3 Q13509 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11044684 0.79 ALDH1A1 (0.49) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL31469987 0.78 CHEK1 (0.47) MAPTALDH1A1KDM4EGAASMN1; SMN2
SCHEMBL9549917 0.78 LMNA (0.48) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL9550084 0.78 LMNA (0.48) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL9549959 0.77 LMNA (0.47) LMNAALDH1A1CYP1A2CYP3A4CYP2D6
SCHEMBL8532730 0.76 BRD4 (0.52) LMNAMAPTALDH1A1GAASMN1; SMN2
SCHEMBL9549902 0.76 LMNA (0.46) LMNAMAPTALDH1A1KDM4EGAA
SCHEMBL8533683 0.74 SLC6A2 (0.44) LMNAACHEMAPTOPRM1BRD4
SCHEMBL31469975 0.74 OPRM1 (0.50) ACHEALDH1A1SMN1; SMN2TSHROPRM1
SCHEMBL6746146 0.74 OPRM1 (0.50) ACHEALDH1A1SMN1; SMN2TSHROPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7119207-B2 Benzoamide piperidine containing compounds and related compounds PFIZER INC (US) 2006-10-10 US disclosed
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds PFIZER INC. 2003-05-08 US disclosed
EP-1272484-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS Pfizer Products Inc. (US) 2003-01-08 EP disclosed
WO-2001077100-A2 BENZOAMIDE PIPERIDINE COMPOUNDS AS SUBSTANCE P ANTAGONISTS PFIZER PRODUCTS INC. (US) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030087925-A1 Benzoamide piperidine containing compounds and related compounds TACR1, VIPR1, VIPR2 LMNA 3704/4885ACHE 968/4885MAPT 2751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.